메뉴 건너뛰기




Volumn 28, Issue 9, 2015, Pages 1109-1110

Belatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation

Author keywords

[No Author keywords available]

Indexed keywords

BELATACEPT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALACTOSE; IMMUNOGLOBULIN; IRBESARTAN; MYCOPHENOLIC ACID; PERINDOPRIL; RAMIPRIL; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; ABATACEPT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

EID: 84938742410     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12574     Document Type: Letter
Times cited : (18)

References (5)
  • 2
    • 84890409760 scopus 로고    scopus 로고
    • Abatacept in B7-1-positive proteinuric kidney disease
    • Yu CC, Fornoni A, Weins A, et al,. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 2013; 369: 2416.
    • (2013) N Engl J Med , vol.369 , pp. 2416
    • Yu, C.C.1    Fornoni, A.2    Weins, A.3
  • 3
    • 79951933190 scopus 로고    scopus 로고
    • Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: A randomized phase II study
    • Rostaing L, Massari P, Garcia VD, et al,. Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study. Clin J Am Soc Nephrol 2011; 6: 430.
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 430
    • Rostaing, L.1    Massari, P.2    Garcia, V.D.3
  • 4
    • 84897008267 scopus 로고    scopus 로고
    • Abatacept in B7-1-positive proteinuric kidney disease
    • Alachkar N, Carter-Monroe N, Reiser J,. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 2014; 370: 1263.
    • (2014) N Engl J Med , vol.370 , pp. 1263
    • Alachkar, N.1    Carter-Monroe, N.2    Reiser, J.3
  • 5
    • 84924964566 scopus 로고    scopus 로고
    • Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
    • Garin EH, Reiser J, Cara-Fuentes G, et al,. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol 2015; 30: 469.
    • (2015) Pediatr Nephrol , vol.30 , pp. 469
    • Garin, E.H.1    Reiser, J.2    Cara-Fuentes, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.